Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis

被引：2
|
作者：
Boyd, MA [1 ]
Burger, DM
Phanuphak, P
Cooper, DA
机构：
[1] Flinders Univ S Australia, Dept Microbiol & Infect Dis, Bedford Pk, SA 5042, Australia
[2] Radboud Univ, Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands
[3] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand
[4] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
来源：
AIDS | 2006年 / 20卷 / 07期
关键词：
D O I：
10.1097/01.aids.0000222090.52035.b2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1083 / 1085
页数：3
相关论文
共 50 条
  • [41] Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals
    Acosta, EP
    Wu, HL
    Hammer, SM
    Yu, S
    Kuritzkes, DR
    Walawander, A
    Eron, JJ
    Fichtenbaum, CJ
    Pettinelli, C
    Neath, D
    Ferguson, E
    Saah, AJ
    Gerber, JG
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (03) : 1358 - 1366
  • [42] Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load
    Arnaiz, JA
    Mallolas, J
    Podzamczer, D
    Gerstoft, J
    Lundgren, JD
    Cahn, P
    Fätkenheuer, G
    D'Arminio-Monforte, A
    Casiró, A
    Reiss, P
    Burger, DM
    Stek, M
    Gatell, JM
    [J]. AIDS, 2003, 17 (06) : 831 - 840
  • [43] Hyperbilirubinemia during therapy with atazanavir boosted with ritonavir in HIV-infected patients in Lodz region
    Wojcik, Kamila
    Jablonowska, Elzbieta
    [J]. HIV & AIDS REVIEW, 2012, 11 (02): : 54 - 56
  • [44] A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction
    Baril, J.
    Conway, B.
    Giguere, P.
    Ferko, N.
    Hollmann, S.
    Angel, J. B.
    [J]. HIV MEDICINE, 2014, 15 (05) : 301 - 310
  • [45] Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients
    Neukam, Karin
    Mira, Jose A.
    Ruiz-Morales, Josefa
    Rivero, Antonio
    Collado, Antonio
    Torres-Cornejo, Almudena
    Merino, Dolores
    de los Santos-Gil, Ignacio
    Macias, Juan
    Gonzalez-Serrano, Mercedes
    Camacho, Angela
    Parra-Garcia, Gines
    Pineda, Juan A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (11) : 2605 - 2614
  • [46] A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir: a study of HIV-infected Zimbabwean adolescents
    Ngara, Bernard
    Zvada, Simbarashe
    Chawana, Tariro Dianah
    Stray-Pedersen, Babill
    Nhachi, Charles Fungai Brian
    Rusakaniko, Simbarashe
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01):
  • [47] Differential Effects of Viremia and Microbial Translocation on Immune Activation in HIV-Infected Patients Throughout Ritonavir-Boosted Darunavir Monotherapy
    BenMarzouk-Hidalgo, Omar J.
    Torres-Cornejo, Almudena
    Gutierrez-Valencia, Alicia
    Ruiz-Valderas, Rosa
    Viciana, Pompeyo
    Lopez-Cortes, Luis F.
    [J]. MEDICINE, 2015, 94 (17) : e781
  • [48] Lack of interaction between atazanavir and proton pump inhibitors in HIV-infected patients treated with ritonavir-boosted atazanavir - Response
    Khanlou, H
    Louie, S
    Farthing, C
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (03) : 394 - 394
  • [49] Efficacy of amprenavir, ritonavir and efavirenz in treatment experienced HIV-infected patients
    Römer, K
    Salzberger, B
    Franzen, C
    Waldschmidt, D
    Fätkenheuer, G
    [J]. AIDS, 2000, 14 : S31 - S31
  • [50] A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir: a study of HIV-infected Zimbabwean adolescents
    Bernard Ngara
    Simbarashe Zvada
    Tariro Dianah Chawana
    Babill Stray-Pedersen
    Charles Fungai Brian Nhachi
    Simbarashe Rusakaniko
    [J]. BMC Pharmacology and Toxicology, 21
12345